Calidi Biotherapeutics, Inc. (CLDI)

Calidi Biotherapeutics Statistics

Total Valuation

CLDI has a market cap or net worth of $17.27 million. The enterprise value is $24.39 million.

Market Cap	17.27M
Enterprise Value	24.39M

Important Dates

The next estimated earnings date is Friday, March 14, 2025, after market close.

Earnings Date	Mar 14, 2025
Ex-Dividend Date	n/a

Share Statistics

CLDI has 19.32 million shares outstanding. The number of shares has increased by 402.94% in one year.

Current Share Class	17.52M
Shares Outstanding	19.32M
Shares Change (YoY)	+402.94%
Shares Change (QoQ)	+46.85%
Owned by Insiders (%)	4.79%
Owned by Institutions (%)	5.00%
Float	15.18M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.19

Current Ratio	0.19
Quick Ratio	0.16
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-28.13

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-136.52%
Return on Capital (ROIC)	-437.34%
Revenue Per Employee	n/a
Profits Per Employee	-$681,610
Employee Count	41
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, CLDI has paid $8,000 in taxes.

Income Tax	8,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -92.91% in the last 52 weeks. The beta is 1.18, so CLDI's price volatility has been higher than the market average.

Beta (5Y)	1.18
52-Week Price Change	-92.91%
50-Day Moving Average	1.69
200-Day Moving Average	1.81
Relative Strength Index (RSI)	32.62
Average Volume (20 Days)	1,166,512

Short Selling Information

The latest short interest is 585,626, so 3.03% of the outstanding shares have been sold short.

Short Interest	585,626
Short Previous Month	161,034
Short % of Shares Out	3.03%
Short % of Float	3.86%
Short Ratio (days to cover)	0.88

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-27.57M
Pretax Income	-29.96M
Net Income	-27.95M
EBITDA	-27.17M
EBIT	-27.57M
Earnings Per Share (EPS)	-$5.51

Balance Sheet

The company has $1.90 million in cash and $9.02 million in debt, giving a net cash position of -$7.13 million or -$0.37 per share.

Cash & Cash Equivalents	1.90M
Total Debt	9.02M
Net Cash	-7.13M
Net Cash Per Share	-$0.37
Equity (Book Value)	-9.80M
Book Value Per Share	-0.93
Working Capital	-9.36M

Cash Flow

In the last 12 months, operating cash flow was -$19.46 million and capital expenditures -$81,000, giving a free cash flow of -$19.54 million.

Operating Cash Flow	-19.46M
Capital Expenditures	-81,000
Free Cash Flow	-19.54M
FCF Per Share	-$1.01

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CLDI does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-402.94%
Shareholder Yield	-402.94%
Earnings Yield	-161.85%
FCF Yield	-113.16%

Analyst Forecast

The average price target for CLDI is $16.67, which is 1,764.86% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$16.67
Price Target Difference	1,764.86%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

The last stock split was on July 15, 2024. It was a reverse split with a ratio of 0.1:1.

Last Split Date	Jul 15, 2024
Split Type	Reverse
Split Ratio	0.1:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1